A new orally administered norovirus vaccine tablet has demonstrated promising safety and immunogenicity in older adults.

Q4 2024 Earnings Call Transcript March 12, 2025 Nektar Therapeutics misses on earnings expectations. Reported EPS is $-0.15 ...